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Summary
Ambruticins and jerangolids are structurally related
antifungal polyketides produced by Sorangium
cellulosum strains. Comparative analysis of the gene
clusters and characterization of compounds produced
by gene knockout strains suggested hypothetical
schemes for biosynthesis of these compounds. Poly-
ketide synthase (PKS) architecture suggests that the
pyran ring structure common to ambruticins and
jerangolids forms by an intramolecular reaction on
a PKS-bound intermediate. Disrupting ambM, encod-
ing a discrete enzyme homologous to PKS C-methyl-
transferase domains, gave 15-desmethylambruticins.
Thus, AmbM is required for C-methylation, but not
pyran ring formation. Several steps in the post-PKS
modification of ambruticin involve new enzymology.
Remarkably, the methylcyclopropane ring and puta-
tive carbon atom excision during ambruticin biosyn-
thesis apparently occur on the PKS assembly line.
The mechanism probably involves a Favorskii rear-
rangement, but further work is required to elucidate
these complex events.
Introduction
Ambruticins and jerangolids are unusual polyketides
produced by strains of Sorangium (Polyangium) cellulo-
sum [1–3]. They inhibit fungal growth by interfering with
osmoregulation [4], presumably via the high-osmolarity
glycerol (HOG) protein kinase signaling pathway, as
shown for the phenylpyrroles [5, 6]. Ambruticins have
shown no significant adverse effects in animals [7],
and are attractive leads for antifungal drug develop-
ment. However, total synthesis of these compounds is
expensive, and a biological production process would
be preferred.
These structurally related compounds share a feature
consisting of a pyran ring connected to a branched
alkene chain with the double bonds out of conjugation
(Figure 1). Where jerangolid has a six-membered lactone
ring, ambruticin has a rare methylcyclopropane ring and
a second pyran ring. The major ambruticins differ at C5,
having either a hydroxyl or an amino group methylated
to different levels. The unusual precursor origin of car-
bon atoms in ambruticin, first reported in 1995 [8], and
confirmed by us (unpublished data), is shown in Figure 1
for reference. Most strikingly, feeding of [2-13C]acetate
gives coupling between C4 and C5, clearly indicating
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from the polyketide chain following its assembly. Car-
bon atom excision is rare, except apparently for certain
dinoflagellate polyketides [8–10]. Ambruticin is the first
polyketide produced by a genetically tractable organism
that includes carbon atom excision in its biosynthesis.
The mechanism has been proposed to involve a Favor-
skii rearrangement [8].
Modular polyketide synthases (PKSs) use an assem-
bly line mechanism, and most modules follow rules
that have emerged from genetic engineering experi-
ments that gave a predicted outcome [11–14]. A typical
module selects an extender unit based on the specificity
of its acyl transferase (AT) domain, and condenses it
with the growing chain using its ketoacyl synthase (KS)
domain. An acyl carrier protein (ACP) domain with a
phosphopantetheine prosthetic group presents the
extender unit to the KS domain for condensation, thus
acquiring the extended polyketide chain, which can be
further modified at the nascent b-ketone by the action
of keto reductase (KR), dehydratase (DH), or enoyl re-
ductase (ER) domains, when present, and then passed
to the next module, which can be a thioesterase (TE)
domain, for release. It was recently shown that PKS
modules derived from unrelated sources can be joined
to obtain functional bimodular PKSs [15], and this ap-
proach is being extended [16]. On the other hand,
many PKS modules deviate from ‘‘textbook biosynthetic
logic’’ [13], and PKS engineering can fail for unknown
reasons even when the modules are similar to those
that have been successfully engineered [17]. There is
still much about PKS enzymology we do not understand.
Here, we have analyzed the ambruticin and jerangolid
gene clusters, and have assigned putative biosynthetic
roles to most of the encoded enzymes. Most PKS mod-
ules resemble those shown to follow the canonical bio-
synthetic logic, allowing polyketide assembly on those
modules to be predicted with good confidence. How-
ever, the PKS modules coinciding with unusual struc-
tural features—notably the pyran ring structure shared
by both compounds, and the carbon atom excision
and methylcyclopropane ring of ambruticin—have un-
usual domain organization, suggesting that novel mech-
anisms occur on the PKS assembly line. By analyzing
gene disruptions, plausible schemes are proposed
that should provide a framework for further studies on
these complex pathways.
Results and Discussion
Cloning and Sequencing of the Gene Clusters
S. cellulosum strains So ce10 and So ce307 produce, re-
spectively, ambruticins and jerangolids. BLAST analy-
ses of cosmid end sequences (w600 andw1000 reads
of w600 bp from So ce10 and So ce307) revealed,
respectively, 6 and 10 cosmids encoding modular PKS
sequence. Polyunsaturated fatty acid (PUFA) synthase
sequences [18] were also seen. Assuming a genome
size of 12 Mb for S. cellulosum [19], each strain appar-
ently encodes w120 kb of modular PKS sequence (not
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types: one most similar to polyene or polyether PKS, an-
other closest to epothilone or myxothiazol PKS [20–22],
and a third closest to PKSs in which the AT domains are
absent from the modules, such as those for pederin and
leinamycin [23, 24]. Thus, the strains appear to have
three PKS gene clusters, each related between the
strains.
Mariner transposon mutagenesis of So ce10 [25] gave
mutants unable to inhibit the growth ofCandida parapsi-
lopsis and the insertions, in most cases, were in PKS
sequence. Fortuitously, the sequence of one of these in-
sertions (K433-47.2) matched that at the end of a cosmid
(pKOS344-112E), and this cosmid was found to encode
a PKS loading module and seven elongation modules
with a domain organization essentially consistent with
the structure of ambruticin (details provided sub-
sequently here). Regions to the left and right of the
pKOS344-112E insert were cloned from additional
transposon mutants (see Experimental Procedures).
Sequencing these clones, as well as a BAC (pKOS375-
123.5K3), provided a contiguous sequence of over
100 kb, containing the ambruticin gene cluster (Gen-
Bank accession number: DQ897667). Transposon inser-
tions were found in several locations spanning the entire
length of the ambruticin PKS and, by LC/MS, none of the
mutants produced any ambruticin-related compound.
Five cosmids from the So ce307 library had end
sequences at least 92% identical with regions of cosmid
pKOS344-112E from So ce10, three of which (pKOS344-
130A, -B, and -C) provided over 67 kb of contiguous
sequence (GenBank accession number: DQ897668).
Figure 1. Structures of Ambruticins and Jerangolids and Organiza-
tion of the Biosynthetic Gene Clusters
Shown are the most prevalent compounds from wild-type and
some of the mutants described here. Also shown is the precursor
origin of carbon atoms in ambruticin VS3. Gray lines under each
gene cluster highlight regions that differ between the two. The
PKS genes are represented by open arrows; other biosynthetic
genes are represented by closed arrows, and nonbiosynthetic
genes, some possibly involved in regulation, are gray.Although transposon mutants of So ce307 could be
generated, we were unable to screen them. Moreover,
several attempts to disrupt genes in So ce307 were
unsuccessful. Despite this, the structure predicted
from the genes found in this cluster matched that of jer-
angolid (as detailed subsequently here), and comparing
the two clusters was useful in predicting biosynthesis.
Organization of the Gene Clusters
Figure 1 shows the cluster organization, and Table 1
provides key features of each gene. The first four PKS
genes (ambA–D and jerA–D) and the ambM/jerM genes
are >90% identical between the clusters. The ambA/jerA
and ambM/jerM genes define the boundaries for a set of
genes in both clusters that appear to encode bio-
synthetic functions; these genes are designated with
letters. Genes on either side of these biosynthetic
genes, some possibly involved in regulating expression,
have been designated with numbers. It is apparent that
these clusters evolved from an ancestral cluster that
produced a structurally related compound.
In both clusters, the PKS genes, along with some non-
PKS genes, are oriented in the same direction in what
appears to be a single transcription unit, starting with
ambA/jerA and extending to ambJ or jerF. Most genes
in these presumptive PKS operons appear to be trans-
lationally coupled, or the intergenic regions are short.
Upstream of this operon is a w1.8 kb region with re-
duced G+C content, containing no open reading frame
(ORF) with the typical G+C bias in the third codon posi-
tion or giving a significant BLAST hit. Further upstream
are three genes encoding possible components of
two-component regulators [26]. The jer4/amb4 genes
are very similar to the atoC gene of Escherichia coli
(43% identity), which encodes a response regulator
component. The jer3/amb3 and jer5/amb5 genes
encode putative sensor kinase components, with jer3/
amb3 translationally coupled to jer4/amb4. The amb3
gene has a large in-frame deletion relative to jer3, delet-
ing the conserved histidine residue. The jer1/amb1
genes encode homologs of the LysR family of transcrip-
tion regulators [27]. At the other end of both clusters is
a gene (jer7/amb7) for a hybrid histidine kinase that
resembles a fungal homolog involved in the HOG path-
way, and which may be the target of ambruticin and
other antifungal agents [5].
N-Methylation of Ambruticin VS5 and Formation
of the cis-20,21 Double Bond
Disrupting ambS in So ce10, which encodes a methyl
transferase (MT) homolog, gave primarily production of
ambruticin VS5 and none of the N-methylated ambruti-
cins (Figure 2). Thus, AmbS catalyzes sequential
N-methylations of VS5 to give VS4, VS3, and VS1. LC/
MS analysis verified the absence of the VS4, VS3, and
VS1 compounds, and revealed that the small peak elut-
ing at 5.4 min in Figure 2 had a mass of 475.3 amu, con-
sistent with dihydroambruticin VS5. Purification and
NMR analysis of this compound (M. Shimazu, G. Bu-
chanan, J. Gallazo, and P. Licari, personal communica-
tion) showed it to be 20,21-dihydroambruticin VS5, with
the stereochemistry at C21 shown in Figure 1. Upon
close inspection of LC/MS data, these dihydro analogs
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Gene(s) % Identity Size (Amino Acid Residues) Homology (Best E Value)
jer1/amb1 84 316 LysR-family transcriptional regulator (4e-36)
amb2 — 406 Cytochrome P450 hydroxylase (1e-52)
jer3/amb3 — 277 Sensor kinase (5e-72)
jer4/amb4 95 461 Response regulator (M. xanthus ntrC; e-150)
jer5/amb5 87 475 Sensor kinase (M. xanthus gene, 2e-72)
jer6/amb6 86 477 Conserved hypothetical protein (1e-69)
jerA/ambA 93 1126 PKS loading module
jerB/ambB 94 3689 PKS modules 1 and 2
jerC/ambC 95 3655 PKS modules 3 and 4
jerD/ambD 90 1892 PKS module 5
JerE — 2870 PKS modules 6 and 7 (with TE)
JerF — 228 O-methyl transferase (S. thioluteus, 7e-49)
jerP/ambP 78 352 Rieske FeS cluster protein; dioxygenase (9e-17)
jerO/ambO 78 376 Flavin-dependent mono-oxygenase (e-76)
jerL — 356 Rieske FeS cluster protein; JerP/AmbP (2e-39)
jerM/ambM 95 395 PKS C-methyl transferase domain (4e-9)
jer7/amb7 95 2078 Hybrid sensor kinase response regulator (0.0)
ambE — 3507 PKS modules 6 and 7
ambF — 2197 PKS module 8 (unusual domain organization)
ambI — 439 Flavin-dependent mono-oxygenase (pedG, e-107)
ambG — 736 Adenylation-thiolation didomain (e-83)
ambH — 1766 PKS module 9 (with TE)
ambJ — 473 Flavin-dependent epoxidase (monCI, nanO, 2e-54)
ambN — 542 Aldehyde dehydrogenase (8e-75)
ambQ — 534 Metal coordination motif of desaturases (3e-56)
ambR — 446 Glutamate semialdehyde aminotransferase (6e-69)
ambS — 359 Methyl transferase (4e-19)
amb8 — 235 Transcription regulator homologue (3e-13)
amb9 — 372 NADH:flavin oxidoreductase (e-117)
Percent identity compares homologs between the clusters; size in amino acid residues is given for the larger of the two proteins, if encoded in
both clusters; the homology found by PBLAST is given, except for the PKSs, where the module content is given.appear to be present at low levels in wild-type culture
extracts.
Disruption of either ambP or ambO gave mutants that
produced only the 20,21-dihydroambruticins and none
of the compounds having a 20,21-double bond (Fig-
ure 2). This was supported by LC/MS data and the fact
that the putative 20,21-dihydroambruticin VS5 peak
co-eluted with a standard (M. Shimazu, G. Buchanan,
J. Gallazo, and P. Licari, personal communication). The
relative level (and estimated absolute level) of each
20,21-dihydroambruticin was similar to that of each
corresponding ambruticin produced by the wild-type,
indicating that the catalytic efficiency of the other bio-
synthetic steps is not significantly affected by the pres-
ence or absence of this double bond. Disruption of
ambN (discussed below) led to production of both
20,21-dihydro ambruticins and the wild-type ambruti-
cins in approximately equal amounts, indicating that
the ambN disruption had a polar effect on ambO/
ambP expression. Since no wild-type compounds
were detected in extracts from cultures of the ambO2
strain, AmbO appears to be essential for desaturation.
The antifungal activity of each dihydroambruticin was
essentially equal to the wild-type compound.
AmbO is related to FAD-dependent monooxygenases
(FMOs) that detoxify xenobiotics in plants and animals
[28, 29]. AmbP is a novel Rieske 2Fe-2S cluster protein,
having little similarity to other proteins in the Genbank
database beyond the motif for coordination of the 2Fe-
2S cluster. Recent work has shown that, for the amino-
pyrrolnitrin oxygenase [30] and other Rieske oxygenasesystems [31], the Rieske 2Fe-2S cluster protein contains
the catalytic site for substrate oxygenation, with a
flavoenzyme donating electrons from NADPH to the
Rieske protein. These systems thus have more catalytic
versatility than previously thought.
The jerangolid gene cluster also encodes close homo-
logs of both AmbO and AmbP. Moreover, the genes are
similarly organized in the two clusters. The end-to-end
sequence identity for both is 78%, strongly suggesting
that formation of the cis-13,14 double bond of jerangolid
involves JerO and JerP. The jerangolid gene cluster also
encodes a second Rieske 2Fe-2S cluster protein (JerL)
that is 30% identical to JerP or AmbP. Jerangolid A is
derived from jerangolid D by hydroxylation of the allylic
C18 position, and JerL may be involved in catalyzing this
hydroxylation, sharing JerO as the electron donor.
Disruption of ambM Gives 15-Desmethylambruticins
The ambM2 mutant produced a distinct profile of com-
pounds (Figure 2), with the most prevalent having the
same mass and a similar retention time as ambruticin
VS4. Purification and NMR characterization (see the
Supplemental Data available with this article online) indi-
cated it was 15-desmethylambruticin VS3. LC/MS anal-
ysis showed that the ambM2 mutant also produced
compounds with masses and retention times consistent
with 15-desmethylambruticin VS5 and 15-desmethy-
lambruticin S, which were not observed in extracts of
the wild-type strain. Thus, the ambM2 mutant appar-
ently produces a 15-desmethyl version of each of the
wild-type ambruticins. The relative amounts of these
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compounds, indicating that the absence of a methyl
group at C15 affects the substrate preferences of
some post-PKS enzymes. Antifungal activity of the
15-desmethyl analogs was nearly equal to that of the
wild-type compounds.
PKS modules use integral MT domains to methylate
the a-carbon after incorporation of an acetate unit [23]
or create a gem-dimethyl [20, 21]. Neither the ambruticin
nor jerangolid PKS has an integral MT domain in module
4, where methylation (at C15 or C8, respectively) would
occur in the PKS assembly line. Instead, the clusters
encode AmbM or JerM, which have similarity to PKS
C-methyltransferase domains (31% identity and 43%
similarity over 216 residues to an MT domain in the
leinamycin cluster of Streptomyces atroolivaceus [23]),
suggesting that they act during polyketide assembly.
Carbanion formation at C15 in 15-desmethylambruticins
Figure 2. HPLC Chromatograms of Culture Extracts for Wild-Type
and the ambS2, ambP2, and ambM2 Mutants
The ambO2 and ambP2 mutants gave identical chromatograms.
Strains were grown under the same conditions and analyzed using
the VS method (see Experimental Procedures), which resolves the
VS compounds. Peaks for compounds that were purified and char-
acterized are indicated.should be very difficult (predicted pKa > 15), which
makes post-PKS C-methylation seem unlikely.
A Hypothetical Scheme for the PKS Assembly Line
up to Module 5
Figure 3A shows the organization of catalytic domains in
the first four PKS polypeptides homologous between
the clusters and a hypothetical model for synthesis of the
structure common to ambruticin and jerangolid. The
PKS modules are assumed to follow the rules most
commonly observed for polyketide assembly [11–
14], and all domains appear to be functional (they
align with known functional domains and contain the
catalytic residues identified in such domains). Module
2 contains an ER consistent with production of 20,21-
dihydroambruticins by the ambO2 and ambP2 mutants.
The stereochemistry of this reduction is established
from the structure of 20,21-dihydroambruticin VS5
(M. Shimazu, G. Buchanan, J. Gallazo, and P. Licari, per-
sonal communication). The AT4 domain has sequence
motifs typical for malonyl-CoA substrate specificity
[32, 33], consistent with an acetate origin for these
carbon atoms.
Formation of the pyran ring structure shared by am-
bruticins and jerangolids seems most likely to occur
on the PKS by conjugate addition of the hydroxyl to
the dienoic acylthioester of the module 4 intermediate,
as shown in Figure 3A. The resulting enolate could be
captured at the a-carbon (destined to be C15 of ambru-
ticin or C8 of jerangolid) by either C-methyl transfer or
Figure 3. Hypothetical Scheme for Biosynthesis of Jerangolid
(A) Assembly of the structure common to ambruticin and jerangolid
on the PKS.
(B) A hypothetical pathway for completion of jerangolid bio-
synthesis.
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omitted, the hypothetical PKS intermediates predicted
do not provide a plausible mechanism for its subse-
quent formation. Compounds missing this shared struc-
ture were not detected in culture broths of wild-type or
mutant strains, arguing against a post-PKS mechanism.
Although C-methyl transfer on PKS module 4 could
follow ketoreduction, when a carbanion would be stabi-
lized by adjacent carbonyls, why would module 4 use
this mechanism instead of a methylmalonyl-specific
AT domain? This unusual mechanism requires further
investigation.
The rest of the jerangolid PKS modules are predicted
to catalyze chain elongation and b-carbon processing
reactions typical of modular PKSs (Figure 3B). The TE
domain of module 7 probably forms the six-membered
lactone ring during release of the product. The last
gene in the putative jerangolid PKS operon (jerF) en-
codes an O-methyltransferase (OMT) with 44% and
40% identity, respectively, to an OMT in the aureothin
cluster of Streptomyces thioluteus [34] and to EncK
from the enterocin cluster of Streptomyces maritimus
[35]. JerF is predicted to methylate the enol tautomer
of the C3 ketone to give the methyl enol ether, which
has been seen for OMT domains in myxothiazol PKS
modules [22]. As already discussed, JerO and JerP are
predicted to introduce the cis-13,14 double bond of
Figure 4. HPLC Chromatograms of Culture Extracts for the ambR2,
ambQ2, and ambJ2 Mutants
Strains were grown under the same conditions and analyzed using
the S method (see Experimental Procedures), which resolves am-
bruticins not having a nitrogen at C5. For reference, the chromato-
gram of the wild-type strain with this HPLC method is similar to that
of the ambR2 mutant, except that the 5-ketoambruticin peak is less
than half the size.jerangolid, and the other Rieske 2Fe-2S cluster protein
encoded by jerL is predicted to hydroxylate C18. The
preferred order of these post-PKS steps is unknown.
Disruption of ambR Blocks Production
of Ambruticins with an Amino Group at C5
Strains carrying a disruption of ambR produced mostly
ambruticin S, together with some 5-keto ambruticin,
but no ambruticins having a nitrogen at C5. Figure 4
shows chromatograms at 220 nm using a method that
resolves acidic ambruticins, but not the zwitterionic VS
compounds. Extracts were also analyzed by the VS
method and by LC/MS. Wild-type So ce10 and all mutant
strains, except the ambJ knockout, produced 5-keto
ambruticin (identified by its coelution with a standard
prepared by oxidation of ambruticin S, as described in
Experimental Procedures). The ambR2 mutant appears
to accumulate more 5-keto ambruticin than the other
strains. Thus, AmbR presumably transfers an amino
group from an amino donor substrate to 5-keto ambru-
ticin. The sequence of AmbR is most similar to gluta-
mate semialdehyde aminomutases [36] and to 4-amino-
butyrate:2-ketoglutarate aminotransferases [37], which
catalyze a step of the g-aminobutyrate (GABA) shunt.
Thus, the amino donor substrate for AmbR could be
glutamate or 4-aminobutyrate.
AmbN is closely related to another enzyme of the
GABA shunt, succinate semialdehyde dehydrogenases.
Disruption of ambN increased the relative level of 20,21-
dihydro analogs, due to a polar effect on expression of
ambO and/or ambP (see previous text here), but had
no effect on the relative level of compounds with differ-
ent C5 functional groups. Since this disruption truncated
22% of the C terminus, residual AmbN activity in this
mutant seems unlikely, Thus, AmbN either has no role
in ambruticin biosynthesis, or its function is comple-
mented by another gene.
Disruption of ambQ Causes the Appearance
of the C5 Epimer of Ambruticin S
Disruption of ambQ gave nearly wild-type levels of am-
bruticin S and the VS series, but also gave a significant
amount of a new peak (Figure 4) that, by LC/MS analysis,
had the same mass as ambruticin S. Purification and
NMR characterization showed that it is the C5 epimer
of ambruticin S, previously named ambruticin F. AmbQ
apparently prevents accumulation of ambruticin F, as
its level is very low in the wild-type. Since the ambQ2
mutant still produced the wild-type ambruticins, either
this disruption left AmbQ partially functional or another
enzyme complements its function. AmbN, the succinate
semialdehyde dehydrogenase homolog mentioned pre-
viously here, may possibly catalyze redox at C5, with
AmbQ complementing the ambN disruption. AmbQ is
homologous to a large family that includes the sterol de-
saturases and other oxidoreductases with a diiron clus-
ter [38]. AmbQ is most similar to bacterial proteins in this
family that do not have a defined function (e.g., 39%
identity and 53% similarity over 312 residues to a
Pseudomonas putida protein identified from genome
sequencing). AmbQ may preferentially use ambruticin
F as a substrate and convert it to 5-ketoambruticin, a
reaction that appears consistent with those catalyzed
by this enzyme family.
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PKS Product
The most prevalent compound produced by the ambJ2
mutant (at 11 min in Figure 4) had a mass [M-H]2 of
457.2975 amu, and was named ambruticin J. High-purity
material was difficult to obtain, because the compound
undergoes solvolysis, as discussed subsequently here.
Nevertheless, the NMR data (see Supplemental Data)
was consistent with the structure shown at the top of
Figure 5. The chemical shifts and coupling constants
(where they could be determined) were either close to
those previously reported for ambruticin S [1, 39], or
differed as would be expected by the structural differ-
ences. Most importantly, the shifts and coupling con-
stants for C6 and C7 were consistent with a trans double
bond. The relative stereochemistry between the C3 and
C5 hydroxyl groups was determined by NMR analysis of
the acetonide methyl ester of ambruticin J. Compared
with ambruticin J, the acetonide methyl ester gave
new carbon signals in CDCl3 at 98.9 ppm (the acetal car-
bon), 51.6 ppm (the methyl ester carbon), and 30.1 and
19.7 ppm (the acetonide C[2] methyl carbons). The sig-
nals for C3, C4, and C5 also were slightly changed rela-
tive to those for ambruticin J, as would be expected.
From the work of Rychnovsky et al. [40], the shifts for
the acetonide C(2) methyl carbons and the acetal carbon
indicate a syn configuration for the two hydroxyls. Thus,
assuming the stereochemistry at C3 previously deter-
mined for ambruticin S [1, 39], the stereochemistry at
C5 is as shown in Figure 5. The antifungal activity of am-
bruticin J was less than that of ambruticin S, but was still
significant.
Minor compounds produced by the ambJ2 mutant
eluted at retention times of 8.5 and 14.3 min (Figure 4),
and these were also purified and characterized. The
high-resolution masses [M-H]2 were 457.2959 and
471.3102 amu, respectively, and both had UV spectra
typical of conjugated trienes. NMR spectrometry con-
firmed that the structures of these compounds were
consistent with hydrolysis and methanolysis, respec-
tively, of ambruticin J, where C12 is apparently attacked
by solvent to open the cyclopropane ring, followed by
conjugate loss of the C5 hydroxyl. Incubation of ambru-
ticin J with deuterated methanol and 0.1% acetic acid
gave the methanolysis product having a mass [M-H]2
of 474.3518 amu, proving that methanolysis occurs
spontaneously. Since these compounds eluted as single
peaks by HPLC, this solvolysis probably follows an SN2
mechanism. The ambJ2 mutant also produced some
early-eluting compounds (Figure 4) with the mass of am-
bruticin J plus an oxygen atom. The UV spectra of most
matched that of ambruticin J, consistent with a conju-
gated diene, while some had a conjugated triene. These
compounds may arise by other cyclopropane ring-
opening mechanisms (e.g., protonation of a C5 ketone
version of ambruticin J) could lead to a variety of prod-
ucts via carbocation rearrangements. These experi-
ments show that ambruticins lacking a cyclopropane
ring arise by solvolysis, and are not biosynthetic inter-
mediates. Presumably, the wild-type pathway avoids in-
termediates prone to such ring opening.
AmbJ is a homolog of epoxidases found in polyether
clusters, where they catalyze epoxidation of double
bonds, with subsequent SN2 displacement, to formether bridges [41–43]. Thus, as shown in Figure 5, we be-
lieve that ambruticin J is released by the PKS and is con-
verted to ambruticin F by the AmbJ epoxidase. Attack of
the epoxide by the C3 hydroxyl to form the pyran ring
may be a spontaneous reaction, or AmbJ may play
a role. The roles of AmbQ and AmbN in redox conver-
sions and hydroxyl stereochemistry at C5 remain to be
determined, but it seems clear that AmbR catalyzes
amino transfer to 5-ketoambruticin. Omitted from Fig-
ure 6 for clarity is formation of the cis-20,21 double
bond catalyzed by AmbO and AmbP, since this reaction
apparently can happen at any point in the pathway, per-
haps even while the intermediates are attached to the
PKS. Also not shown are the sequential N-methylations
catalyzed by AmbS, which converts ambruticin VS5 into
VS4, VS3, and VS1.
Biosynthesis on Ambruticin PKS Modules 6–9
Figure 6 shows the domain organization of ambruticin
PKS modules 6–9 and a possible scheme for biosynthe-
sis on these modules. The domain organization of mod-
ule 9 predicts that it inserts a malonyl unit, reduces the b-
ketone, and releases the PKS product, which we believe
is ambruticin J (Figure 5). Thus, the intermediate passed
to module 9 should be that labeled D in Figure 6. Be-
cause the carboxyl carbon originally between C4 and
C5 is apparently excised from the chain, C1–C9 of
ambruticin must arise from five malonyl units. Module
6 apparently condenses a methylmalonyl unit with the
chain and converts the nascent b-ketone to a double
bond. These carbon atoms become part of the
Figure 5. Proposed Pathway for Post-PKS Tailoring of Ambruticin
The reactions to introduce the 20,21-cis-double bond and methyl-
ation of the C5 amino group are omitted for clarity.
Ambruticin and Jerangolid Biosynthesis
1283Figure 6. Possible Scheme for the PKS As-
sembly Line on Modules 6–9
Between modules 7 and 9, the hypothetical
intermediates are labeled A to D for refer-
ence. It remains to be determined which
ACP carries what intermediate at any given
point. See text for details.methylcyclopropane ring. Module 7 has the catalytic
machinery to condense malonyl units with the chain
and convert each b-ketone to a double bond, while the
unusual module 8 discussed subsequently here has nei-
ther a KR nor DH domain. Thus, module 7 most probably
catalyzes three iterative chain elongations followed by
a KS8 condensation, to give the intermediate labeled A
in Figure 6. Programmed iteration has been observed
in several other modular PKSs, and the phenomenon
has been reviewed [44].
AmbF begins with an ACP domain that may serve as
the module 7 ACP, where it is missing. KS8 is most sim-
ilar to those of AT-less PKS modules, and probably cat-
alyzes a typical condensation. Breaks between domains
other than ACP and KS on functionally sequential poly-
peptides are not uncommon for AT-less PKS modules
[23, 24]. Module 8 also lacks an AT domain and KS8 is
followed by two tandem ACP domains. In the mupirocin
PKS, tandem ACPs have been shown to act in parallel or
in series [45]. AmbF also has unusual repeated motifs
that may be important for function. The ambruticin clus-
ter does not encode a discrete AT for the AT-less mod-
ule 8. Perhaps the AT of module 7, which can, appar-
ently, load the N-terminal ACP of module 8, can also
load an ACP for the KS8 condensation.
Carbon atom excision and methylcyclopropane ring
formation could occur by a Favorskii rearrangement (A
to B), followed by hydrolysis of the cyclopropanone (B
to C), as shown in Figure 6. The location of the catalytic
site needed to set the three chiral centers around the
methylcyclopropane ring is unknown. The strain energy
of a cyclopropane ring is about 27 kcal $ mole21, and
a pi bond has about 22 kcal $ mole21 more energy than a
sigma bond. Thus, once the cyclopropanone is hydro-
lyzed to a C5 carboxylate, the overall reaction from A
to C should be energetically favored. Following the tan-
dem ACP domains of module 8 is a domain homologous
to a/b-hydrolases (H domain in Figure 6). It has 26%
identity over 280 residues to a 3-oxoadipate enol-lactone hydrolase from Caulobacter crescentus and
26% identity over 240 residues to the TE in the leinamy-
cin cluster [23]. Since the polyketide intermediate is not
released at this point, the H domain may be involved in
hydrolytic opening of the cyclopropanone.
Between hypothetical intermediates, C and D, is
decarboxylation and hydroxylation at C5. AmbI is a
FMO closely related to PedG from the pederin cluster
[24] (45% identity; 63% similarity), which was proposed
to catalyze oxidative chain cleavage [24]. A similar reac-
tion may be catalyzed by AmbI to convert intermediate
C to D. An FMO encoded in the enterocin gene cluster
(divergent from PedG or AmbI) has recently been shown
to catalyze a Favorskii rearrangement and carbon atom
excision [9].
The functions of the C-terminal pyridoxal cofactor
binding motif (PX) domain in module 8 and the AmbG
adenylation-thiolation didomain are unknown. The PX
domain is 27% identical and 40% similar to proteins
encoded in the Pseudomonas stutzeri (AAF33137) and
Ralstonia solanacearum (CAD17351) genomes, both of
which were annotated as putative aminotransferases.
This domain is not significantly related to the amino-
transferase domain in the mixed PKS-nonribosomal
peptide synthetase for mycosubtilin in Bacillus subtilis
[46]. AmbG has a very unusual substrate selectivity
code [47, 48] that gives no clue to its substrate. The
presence of both the PX domain and AmbG protein
suggests that an amino group is involved, presumably
transiently, and perhaps these enzymes play a role in
decarboxylation at C5. Clearly, more work is required
to understand this portion of the ambruticin PKS assem-
bly line.
Significance
This work has revealed novel polyketide synthase
(PKS) architecture and suggested novel mechanisms
on the PKS assembly lines leading to ambruticins
Chemistry & Biology
1284and jerangolids. Models for biosynthesis of both poly-
ketides are proposed that can be tested by further
work aimed at exploring these mechanisms in more
detail. The first half of the PKS assembly line appears
to be identical for ambruticins and jerangolids, involv-
ing formation of a pyran ring on the PKS. Disruption of
ambM, encoding a discrete methyl transferase homo-
log, showed that it is required for C-methylation, but
not for pyran ring formation. However, these events
seem likely to be concerted in the wild-type pathways.
Analysis of gene knockout strains suggested a path-
way for post-PKS tailoring of ambruticin involving
several apparently novel enzyme mechanisms. Most
surprisingly, carbon atom excision and formation
of a methylcyclopropane ring appear to occur on the
PKS, probably involving a Favorskii rearrangement.
Despite the apparent complexity of ambruticin biosyn-
thesis, gene disruptions gave strains that produced
novel compounds in good yield. Thus, it may be possi-
ble to exploit these unusual mechanisms for combina-
torial biosynthesis.
Experimental Procedures
Bacterial Strains, Growth Conditions, and DNA Manipulation
S. cellulosum strains So ce10 and So ce307 were obtained from the
Gesellschaft fu¨r Biotechnologische Forschung in Braunschweig,
Germany. P. cellulosum strain 12,601 was obtained from the
National Collections of Industrial Food and Marine Bacteria in
Aberdeen, Scotland. Strains were maintained as previously
described [1, 3].
Genomic DNA was isolated from S. cellulosum, as described in
[49], and cosmid libraries were made in pKOS060-10, a modified ver-
sion of Supercos-1 (Stratagene, La Jolla, CA), in which the 4.2 kb
AfeI fragment was self-ligated to remove the SV40 sequences and
neomycin resistance marker. Library construction followed the
protocol provided with Supercos-1 from Stratagene. BAC DNA
was prepared using the Qiagen large construct kit (Valencia, CA).
Isolation of Transposon-Tagged Mutants
Versions of the mariner transposon system [25] with the phleomycin
resistance marker, both with and without the E. coli R6Kg plasmid
origin (from pMOD-3; Epicentre Biotechnologies, Madison, WI),
were used to generate Sorangium mutants. Clones were grown on
S42 agar medium [49] in 96-well microtiter dishes. After 7 days of
growth, YPD top agar inoculated with Candida parapsilopsis (So
ce10 mutants) was overlayed in each well. After another 2 days,
most wells were clear, but approximately 1% of wells were turbid
due to growth of the yeast, presumably because of lack of produc-
tion of antifungal activity by that mutant. In most cases, the region
into which the transposon had inserted was cloned by cutting geno-
mic DNA from the mutant with restriction enzymes, ligating to circu-
larize, introducing into E. coli EC100 cells (Epicentre) by electropora-
tion, and selecting on phleomycin. This provided the sequence of
the insertion site in each of the nonproducing mutants.
Isolation and Sequencing of Cosmids Containing
the Ambruticin Gene Cluster
The insertion site of transposon mutant K433-47.2 was found near
the end of cosmid pKOS344-112E. After obtaining the complete
sequence of pKOS344-112E and finding that it carried a portion of
the putative ambruticin cluster, a BglII fragment cloned from K433-
47.2 DNA (pKOS375-77Bg) was used to obtain an additional 11 kb
extending out from pKOS344-112E. To extend the existing
sequence further, cosmid libraries were prepared from the DNA of
other transposon mutants (K433-71.5 and K375-93), and those
carrying the transposon were selected on carbenicillin plus phleo-
mycin. After mapping to establish the approximate position of the
transposon within each insert, cosmids from K433-71.5 (pKOS344-
135F) and K375-93 (pKOS344-190) were fully sequenced. BACclones from So ce10 harboring the entire ambruticin cluster also
were isolated, and one (pKOS375-123.5K3) was shotgun se-
quenced. Specific primers were used to improve the quality of
sequence data in a few regions of low coverage.
Isolation of a BAC Containing the Entire Ambruticin
Gene Cluster
Chromosomal DNA was embedded in agarose using the CHEF bac-
terial genomic DNA kit from Bio-Rad (Hercules, CA). So ce10 was
grown in 307 seed medium (0.9% casitone, 0.3% fructose, 0.05%
MgSO4, 0.05% CaCl2, 25 mM HEPES [pH 7.6]) to an OD600 ofw4.0
(w4 3 108 cells/ml). A 20 ml aliquot of cells was centrifuged, resus-
pended in 2 ml of water, and added to 2 ml of melted 2% agarose
from the kit. The agarose cell suspension was aliquoted into plug
molds. After hardening, the agar plugs were placed into lysozyme
buffer, and lysozyme was added to 1 mg/ml. The plugs were incu-
bated at 37C overnight. The next day, the plugs were washed twice
with 50 ml of water and digested with proteinase K. The plugs were
incubated at 50C overnight and washed several times the next day
with TE (10 mM Tris [pH 7.6], 1 mM EDTA). A 6144 clone BAC library
was constructed by Amplicon Express (Pullman, WA) by partially di-
gesting the DNA withBamHI and ligating into pEC1BAC cleaved with
BamHI. The average insert size was about 100 kb.
Clone pKOS375-77Bg was used to probe the BAC library and, of
62 hybridizing clones identified, the end sequence was determined
for 3. One clone (pKOS375-123.5K3) was shotgun sequenced and
found to contain the entire ambruticin gene cluster.
DNA Sequencing and Analysis Methods
Sequencing was done on an ABI 3730 using Big Dye-terminator
chemistry (Applied Biosystems, Foster City, CA). Cosmids in the
modified Supercos-1 backbone were end-sequenced with the fol-
lowing primers: 50-TCTCTGTTTTTGTCCGTGG-30 and 50-TTCCCCG
AAAAGTGCCAC-30. Fosmids or clones in Litmus 28 (New England
Biolabs, Inc., Ipswich, MA) were end-sequenced using standard for-
ward and reverse M13 primers. For shotgun libraries, cosmid DNA
was either partially digested with Sau3AI or sheared with a pair of
250 ml Hamilton syringes joined by a short piece of 0.002 in. ID
PEEK tubing. Fragments in the approximate range of 2–4 kb were
isolated and ligated into pCR-Blunt (Invitrogen, Karlsruhe, Germany)
(cut with BamHI for partial Sau3AI-digested DNA or StuI for sheared
DNA, and dephosphorylated). Sequences were edited and assem-
bled using Sequencher (Gene Codes Corporation, Ann Arbor, MI).
BLAST analysis was done using the National Center for Biotechnol-
ogy Information programs and databases installed on a local Linux
server. Sequences were annotated using MacVector (Accelerys
Software, Inc., San Diego, CA).
Disruption of Genes in So ce10
Gene disruption was achieved by introducing a plasmid into Soran-
gium that could insert into the middle of the gene by a single recom-
bination event. A central fragment of each gene was amplified by
PCR using primers that included in-frame stop codons at each
end. The PCR product was cloned into the unique EcoRV site of
pKOS375-178, which was derived from Litmus 28 by adding the
R6K oriT and a phleomycin resistance cassette. Each knockout con-
struct was transferred from E. coli strain C-2420, containing the
helper plasmid pKOS111-47 [25], into Sorangium by conjugation
as previously described [49]. Transconjugants were selected on
S42 agar containing 50 mg/ml each of kanamycin and phleomycin.
Details for these gene disruptions are given in the Supplemental
Data.
Analysis of Compounds in Culture Broth Extracts
Colonies on S42 agar plates were inoculated into seed medium
(10 g/l maltodextrin, 4 g/l nonfat dry milk, 4 g/l soy peptone, 4 ml/l
glycerol, 1 g/l CaCl2$2H2O, 1 g/l MgSO4$7H2O, 15 mg/l FeCl3$6H2O,
25 mM HEPES, pH 7.6) and grown for 2–3 days at 32C. Production
medium (10 g/l maltodextrin, 5 g/l Pharmamedia, 4 g/l nonfat dry
milk, 4 g/l soy peptone, 4 ml/l glycerol, 1 g/l CaCl2$2H2O, 1 g/l
MgSO4$7H2O, 120 mg/l FeCl3$6H2O, 50 mM HEPES, pH 7.6) contain-
ing 40 g/l XAD1180 was inoculated with 10% seed culture and incu-
bated at 32C for 8 days. After washing the XAD resin with water, the
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to half the original culture volume.
Ambruticins were analyzed by HPLC using two isocratic methods,
one for compounds containing an amino group (43 125 mm Agilent
Nucleosil C18 column; Agilent Technologies, Inc., Santa Clara, CA;
78% methanol, 10 mM ammonium acetate, pH 8.2, 1 ml $ min21),
and another for compounds not containing an amino group (Agilent
Eclipse XDB-C8 4.6 3 150 mm column; 65% acetonitrile, 0.1% ace-
tic acid, 1 ml $ min21). Detection was usually at 220 nm, although am-
bruticin J and its solvolysis products were better detected at 250
and 270 nm, respectively. Quantification used the area under the
peaks relative to a standard curve, where pure compounds were
available. For LC/MS analyses, a gradient method was used (Meta-
Chem Inertsil 4 3 100 mm ODS-3 column; MetaChem, Piddington,
Northampton, UK; 30%–100% acetonitrile, 0.1% acetic acid, 1 ml $
min21) with detection by both an Agilent 1100 system diode array
detector and a Perseptive Biosystems Mariner time-of-flight mass
spectrometer (PerSeptive Biosystems, Framingham, MA).
Purification of Ambruticins and NMR Analysis
Mutant strains were grown at the appropriate scale, as described
previously here. The XAD resin from such cultures was washed
with water and extracted with 0.5 volume of methanol. The extracts
were adjusted to 50% methanol and either 50 mM ammonium ace-
tate (for purification of compounds with an amino group) or 0.1%
acetic acid (for purification of compounds without an amino group)
was added. The crude extract was loaded onto a pre-equilibrated
2.5 3 28 cm column of BakerBond C18 (Mallinckrodt Baker, Inc.,
Phillipsburg, NJ) at 10 ml/min, and the column washed with 2 vol-
umes of 50% methanol (with 50 mM ammonium acetate or 0.1%
acetic acid). Fractions were collected using 80% methanol, and
were analyzed by one of the analytical HPLC methods described
previously here. The ammonium acetate or acetic acid was removed
by adjusting pooled fractions to 40% methanol, loading a Baker-
Bond C18 column (0.5 3 26 cm BakerBond C18), washing with sev-
eral volumes of 40% methanol, and then eluting with 100% metha-
nol. Ambruticin J and its two solvolysis products were further
purified using a Gilson preparative HPLC system with a gradient
method (MetaSil Basic 5 mm, 1503 300 mm column; 25%–90% ace-
tonitrile in water plus 0.1% acetic acid at 10 ml/min).
For NMR analysis, compounds were dried in a vacuum oven at
40C for several hours, dissolved in CD3OD or CDCl3, and analyzed
on a Bruker 400 MHz instrument (Bruker, Billerica, MA).
Synthesis of Ambruticin Derivatives for Structure Elucidation
The acetonide methyl ester of ambruticin J was prepared as follows:
ambruticin J was dissolved in 5:1 benzene:methanol and 1.5 eq of
trimethylsilyldiazomethane (2 M in ether) was added; after 30 min
at room temperature, the methyl ester was purified by chromatogra-
phy on silica with a gradient from 10% acetone in hexane to 50%
acetone in hexane. The methyl ester was dissolved in anhydrous di-
chloromethane, 5 eq of 2-methoxypropene were added, and then
0.05 eq of pyridinium p-toluenesulfonate (as a 20 mM solution in di-
chloromethane) were added. After 30 min, saturated sodium bicar-
bonate was added, the dichloromethane layer was dried and evap-
orated, and the resulting extract was purified by chromatography on
silica using a gradient from pure hexane to 50% acetone in hexane.
Crude 5-ketoambruticin was prepared by dissolving 95 mg of
ambruticin S (0.2 mmol) in dichloromethane (2 ml) and adding
Dess-Martin periodinane reagent (0.4 mmol). After 24 hr stirring at
room temperature, 1 mmol isopropanol was added, followed by
2 ml saturated sodium bicarbonate. The reaction was extracted
with dichloromethane, the dichloromethane was dried and evapo-
rated, and the residue was subjected to chromatography with a
Gilson preparative HPLC system and a gradient method (MetaSil
Basic 5 mm, 150 3 300 mm column; 25%–90% acetonitrile in water
plus 0.1% acetic acid at 10 ml/min).
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